Koganei, Japan

Atsushi Uno


 

Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020-2021

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Atsushi Uno: Innovator in RNA Interference Technology

Introduction

Atsushi Uno is a notable inventor based in Koganei, Japan. He has made significant contributions to the field of RNA interference technology, holding a total of 2 patents. His work focuses on enhancing the effectiveness and stability of RNA molecules for therapeutic applications.

Latest Patents

Uno's latest patents include innovative approaches to chemically-modified siRNA and complexes of polysaccharides with double-stranded RNA. The first patent describes a chemically-modified siRNA that incorporates polydeoxyadenylic acid at the 5' end of the sense strand. This modification enhances resistance against RNase and effectively promotes RNAi activity. The second patent presents a novel double-stranded RNA that improves cellular uptake and resistance to enzymatic degradation while maintaining RNA interference effects. This is achieved through specific structural conditions that optimize the interaction between polysaccharides and RNA.

Career Highlights

Throughout his career, Atsushi Uno has worked with various companies, including Napajen Pharma, Inc. and Napa Jenomics Co., Ltd. His experience in these organizations has allowed him to advance his research and contribute to the development of innovative RNA-based therapies.

Collaborations

Uno has collaborated with notable colleagues in his field, including Sadaharu Higuchi and Hironori Ando. These partnerships have further enriched his research and innovation efforts.

Conclusion

Atsushi Uno's contributions to RNA interference technology highlight his role as a leading inventor in the field. His innovative patents and collaborations demonstrate his commitment to advancing therapeutic applications of RNA.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…